104 related articles for article (PubMed ID: 23851271)
1. Inhibition of tumor growth in a mouse xenograft model by the humanized anti-HGF monoclonal antibody YYB-101 produced in a large-scale CHO cell culture.
Song SW; Lee SJ; Kim CY; Song JK; Jung EJ; Choi YB; Min SW; Oh JW
J Microbiol Biotechnol; 2013 Sep; 23(9):1327-38. PubMed ID: 23851271
[TBL] [Abstract][Full Text] [Related]
2. Preclinical development of a humanized neutralizing antibody targeting HGF.
Kim H; Hong SH; Kim JY; Kim IC; Park YW; Lee SJ; Song SW; Kim JJ; Park G; Kim TM; Kim YH; Park JB; Chung J; Kim IH
Exp Mol Med; 2017 Mar; 49(3):e309. PubMed ID: 28336956
[TBL] [Abstract][Full Text] [Related]
3. YYB-101, a Humanized Antihepatocyte Growth Factor Monoclonal Antibody, Inhibits Ovarian Cancer Cell Motility and Proliferation.
Kim HJ; Heo K
Anticancer Res; 2021 Feb; 41(2):671-678. PubMed ID: 33517271
[TBL] [Abstract][Full Text] [Related]
4. Systemic anti-hepatocyte growth factor monoclonal antibody therapy induces the regression of intracranial glioma xenografts.
Kim KJ; Wang L; Su YC; Gillespie GY; Salhotra A; Lal B; Laterra J
Clin Cancer Res; 2006 Feb; 12(4):1292-8. PubMed ID: 16489086
[TBL] [Abstract][Full Text] [Related]
5. Identification of genomic and molecular traits that present therapeutic vulnerability to HGF-targeted therapy in glioblastoma.
Sa JK; Kim SH; Lee JK; Cho HJ; Shin YJ; Shin H; Koo H; Kim D; Lee M; Kang W; Hong SH; Kim JY; Park YW; Song SW; Lee SJ; Joo KM; Nam DH
Neuro Oncol; 2019 Feb; 21(2):222-233. PubMed ID: 29939324
[TBL] [Abstract][Full Text] [Related]
6. Humanized Anti-hepatocyte Growth Factor Monoclonal Antibody (YYB-101) Inhibits Ovarian Cancer Progression.
Kim HJ; Lee S; Oh YS; Chang HK; Kim YS; Hong SH; Kim JY; Park YW; Lee SJ; Song SW; Kim JJ; Heo K
Front Oncol; 2019; 9():571. PubMed ID: 31355133
[TBL] [Abstract][Full Text] [Related]
7. A novel antagonist anti-cMet antibody with antitumor activities targeting both ligand-dependent and ligand-independent c-Met receptors.
Gonzalez A; Broussas M; Beau-Larvor C; Haeuw JF; Boute N; Robert A; Champion T; Beck A; Bailly C; Corvaïa N; Goetsch L
Int J Cancer; 2016 Oct; 139(8):1851-63. PubMed ID: 27144973
[TBL] [Abstract][Full Text] [Related]
8. Fully human monoclonal antibodies to hepatocyte growth factor with therapeutic potential against hepatocyte growth factor/c-Met-dependent human tumors.
Burgess T; Coxon A; Meyer S; Sun J; Rex K; Tsuruda T; Chen Q; Ho SY; Li L; Kaufman S; McDorman K; Cattley RC; Sun J; Elliott G; Zhang K; Feng X; Jia XC; Green L; Radinsky R; Kendall R
Cancer Res; 2006 Feb; 66(3):1721-9. PubMed ID: 16452232
[TBL] [Abstract][Full Text] [Related]
9. Rapid establishment of CHO cell lines producing the anti-hepatocyte growth factor antibody SFN68.
Song SW; Lee SJ; Kim CY; Han B; Oh JW
J Microbiol Biotechnol; 2013 Aug; 23(8):1176-84. PubMed ID: 23727793
[TBL] [Abstract][Full Text] [Related]
10. A novel rabbit anti-hepatocyte growth factor monoclonal neutralizing antibody inhibits tumor growth in prostate cancer cells and mouse xenografts.
Yu Y; Chen Y; Ding G; Wang M; Wu H; Xu L; Rui X; Zhang Z
Biochem Biophys Res Commun; 2015 Aug; 464(1):154-60. PubMed ID: 26093299
[TBL] [Abstract][Full Text] [Related]
11. A bispecific antibody effectively inhibits tumor growth and metastasis by simultaneous blocking vascular endothelial growth factor A and osteopontin.
Kou G; Shi J; Chen L; Zhang D; Hou S; Zhao L; Fang C; Zheng L; Zhang X; Liang P; Zhang X; Li B; Guo Y
Cancer Lett; 2010 Dec; 299(2):130-6. PubMed ID: 20826049
[TBL] [Abstract][Full Text] [Related]
12. Enhanced cell culture performance using inducible anti-apoptotic genes E1B-19K and Aven in the production of a monoclonal antibody with Chinese hamster ovary cells.
Figueroa B; Ailor E; Osborne D; Hardwick JM; Reff M; Betenbaugh MJ
Biotechnol Bioeng; 2007 Jul; 97(4):877-92. PubMed ID: 17099908
[TBL] [Abstract][Full Text] [Related]
13. A single nutrient feed supports both chemically defined NS0 and CHO fed-batch processes: Improved productivity and lactate metabolism.
Ma N; Ellet J; Okediadi C; Hermes P; McCormick E; Casnocha S
Biotechnol Prog; 2009; 25(5):1353-63. PubMed ID: 19637321
[TBL] [Abstract][Full Text] [Related]
14. Humanized anti-hepatocyte growth factor (HGF) antibody suppresses innate irinotecan (CPT-11) resistance induced by fibroblast-derived HGF.
Woo JK; Kang JH; Kim B; Park BH; Shin KJ; Song SW; Kim JJ; Kim HM; Lee SJ; Oh SH
Oncotarget; 2015 Sep; 6(27):24047-60. PubMed ID: 26090722
[TBL] [Abstract][Full Text] [Related]
15. Initial testing (Stage 1) of TAK-701, a humanized hepatocyte growth factor binding antibody, by the Pediatric Preclinical Testing Program.
Houghton PJ; Kurmasheva RT; Kolb EA; Wu J; Gorlick R; Maris JM; Smith MA
Pediatr Blood Cancer; 2014 Feb; 61(2):380-2. PubMed ID: 24019233
[TBL] [Abstract][Full Text] [Related]
16. Control of culture environment for improved polyethylenimine-mediated transient production of recombinant monoclonal antibodies by CHO cells.
Galbraith DJ; Tait AS; Racher AJ; Birch JR; James DC
Biotechnol Prog; 2006; 22(3):753-62. PubMed ID: 16739959
[TBL] [Abstract][Full Text] [Related]
17. Generation and characterization of a target-selectively activated antibody against epidermal growth factor receptor with enhanced anti-tumor potency.
Yang Y; Guo Q; Xia M; Li Y; Peng X; Liu T; Tong X; Xu J; Guo H; Qian W; Hou S; Dai J; Wang H; Liu R; Guo Y
MAbs; 2015; 7(2):440-50. PubMed ID: 25679409
[TBL] [Abstract][Full Text] [Related]
18. Efficient Selection of Antibodies Reactive to Homologous Epitopes on Human and Mouse Hepatocyte Growth Factors by Next-Generation Sequencing-Based Analysis of the B Cell Repertoire.
Kim S; Lee H; Noh J; Lee Y; Han H; Yoo DK; Kim H; Kwon S; Chung J
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30669409
[No Abstract] [Full Text] [Related]
19. Development and manufacturability assessment of chemically-defined medium for the production of protein therapeutics in CHO cells.
Ling WL; Bai Y; Cheng C; Padawer I; Wu C
Biotechnol Prog; 2015; 31(5):1163-71. PubMed ID: 26013818
[TBL] [Abstract][Full Text] [Related]
20. Optimization of chemically defined feed media for monoclonal antibody production in Chinese hamster ovary cells.
Kishishita S; Katayama S; Kodaira K; Takagi Y; Matsuda H; Okamoto H; Takuma S; Hirashima C; Aoyagi H
J Biosci Bioeng; 2015 Jul; 120(1):78-84. PubMed ID: 25678240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
